![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Saturday, February 01, 2020 5:35:55 PM
The FDA Clearance that BIEL has sought for 19 years, to properly market ActiPatch in the US, is finally a reality.
BIEL, BIEL's OEM Partners, BIEL's Licensing Partners can now advertise ActiPatch as Effective Pain Relief for any Muscles, Joints, Bones, Ligaments, Tendons, and Nerves, not just the Foot/Knee.
The FDA is the 'Gold Standard' around the world for medical related products. ActiPatch is already sold in many countries for use anywhere on the body, now the same can be done in the US and ActiPatch can use the clout of the FDA as added credibility in other countries.
Keith Nalepka is going to be a very busy Sales VP when the FDA PR comes out on Monday morning.
With the light that has been shed on the US Opioid Epidemic, still killing 130 Americans a day, and the long known danger to the Liver and Kidney with OTC Pain Drugs, an effective drug-free pain reliever is urgently needed.
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM